Trial Profile
Phase I/II study of intratumoral injection of DTI-015 [carmustine] prior to tumor resection in patients with recurrent malignant glioma or metastatic neoplasm to brain
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 10 Sep 2009
Price :
$35
*
At a glance
- Drugs Carmustine (Primary)
- Indications Cancer metastases; Glioma
- Focus Therapeutic Use
- 21 Sep 2005 New trial record.